Approval · Notice of Compliance 4452 · 1996
HYDROMORPH.IR: Notice of Compliance 4452
Issued July 24, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4452
- Date
- July 24, 1996
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form - immediate release
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDROMORPH.IR | 02225220 | — |
| HYDROMORPH.IR | 02225239 | — |
| HYDROMORPH.IR | 02225247 | — |
| HYDROMORPH.IR | 02225255 | — |
Medicinal ingredients
- HYDROMORPHONE HCL 1 MG per CAP
- HYDROMORPHONE HCL 2 MG per CAP
- HYDROMORPHONE HCL 4 MG per CAP
- HYDROMORPHONE HCL 8 MG per CAP